In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Dilacoran HTA Drug Master File in Korea (Dilacoran HTA KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Dilacoran HTA. The MFDS reviews the Dilacoran HTA KDMF as part of the drug registration process and uses the information provided in the Dilacoran HTA KDMF to evaluate the safety and efficacy of the drug.
After submitting a Dilacoran HTA KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Dilacoran HTA API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Dilacoran HTA suppliers with KDMF on PharmaCompass.